What does IDEMMED do?

IDEMMED is a general practice in Chapelle-lez-Herlaimont. Private Limited, started on 20 July 2004, 2 establishments.

What is the address of IDEMMED?

The registered office of IDEMMED is located at Rue du Chêne 96, 7160 Chapelle-lez-Herlaimont.

Is IDEMMED still active?

Yes. According to the CBE (29 October 2026) IDEMMED is active, legal situation “Normale toestand”, started on 20 July 2004.

Is IDEMMED registered on Peppol?

Yes, IDEMMED is registered on the Peppol network with ID 0208:0866466653.

What is the enterprise number of IDEMMED?

The enterprise number of IDEMMED is BE0866466653.

When was IDEMMED founded?

IDEMMED was founded on 20 July 2004.

Who are the directors of IDEMMED?

According to the 2024 annual accounts, the directors of IDEMMED are: Pol POPADINEC.

Is IDEMMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 July 2004; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did IDEMMED make in 2024?

IDEMMED posted a profit after taxes of € 38,065 in financial year 2024.

What is the revenue of IDEMMED?

As a small company, IDEMMED is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 201,258.

IDEMMED (Private Limited) - Chapelle-lez-Herlaimont

Dossier IDEMMED, printed on 29 October 2026 from databakkes.be/en/0866466653/idemmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

IDEMMED from Chapelle-lez-Herlaimont, company number BE0866466653, closed financial year 2024 with a result of € 38,065 after tax. For that financial year IDEMMED recorded a gross margin of € 201,258 and equity of € 331,666. Compared with financial year 2023, the result moved from € -48,881 to € 38,065. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2025.

What it is worth Growing

€ 331,666

▲ 13% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 38,065

▲ still € 48,881 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 190,852

▲ 14% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 325,466.

People and assets in 2024

Wage cost

€ 45,673

▲ 15% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 32,603

▼ 29% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 92,821

▲ 34% vs 2023

€ 67,386 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 212,082 Gross margin 2021: € 212,082 First fiscal year in the series	€ 161,084 Gross margin 2022: € 161,084 ▼ 24% vs 2021 (€ 212,082) Unfavourable step	€ 181,994 Gross margin 2023: € 181,994 ▲ 13% vs 2022 (€ 161,084) Favourable step	€ 201,258 Gross margin 2024: € 201,258 ▲ 11% vs 2023 (€ 181,994) Favourable step	▲ 11%
Profit after taxes	€ 90,279 Profit after taxes 2021: € 90,279 First fiscal year in the series	€ 35,597 Profit after taxes 2022: € 35,597 ▼ 61% vs 2021 (€ 90,279) Unfavourable step	€ -48,881 Profit after taxes 2023: € -48,881 ▼ € 84,478 vs 2022 (€ 35,597) Unfavourable step	€ 38,065 Profit after taxes 2024: € 38,065 ▲ € 86,945 vs 2023 (€ -48,881) Favourable step	▲ € 86,945
Equity	€ 306,884 Equity 2021: € 306,884 First fiscal year in the series	€ 342,482 Equity 2022: € 342,482 ▲ 12% vs 2021 (€ 306,884) Favourable step	€ 293,601 Equity 2023: € 293,601 ▼ 14% vs 2022 (€ 342,482) Unfavourable step	€ 331,666 Equity 2024: € 331,666 ▲ 13% vs 2023 (€ 293,601) Favourable step	▲ 13%
Total debts	€ 144,361 Total debts 2021: € 144,361 First fiscal year in the series	€ 111,193 Total debts 2022: € 111,193 ▼ 23% vs 2021 (€ 144,361) Favourable step	€ 110,138 Total debts 2023: € 110,138 ▼ 1% vs 2022 (€ 111,193) Favourable step	€ 92,821 Total debts 2024: € 92,821 ▼ 16% vs 2023 (€ 110,138) Favourable step	▼ 16%
Cash	€ 165,601 Cash 2021: € 165,601 First fiscal year in the series	€ 145,626 Cash 2022: € 145,626 ▼ 12% vs 2021 (€ 165,601) Unfavourable step	€ 167,276 Cash 2023: € 167,276 ▲ 15% vs 2022 (€ 145,626) Favourable step	€ 190,852 Cash 2024: € 190,852 ▲ 14% vs 2023 (€ 167,276) Favourable step	▲ 14%
Land & buildings	€ 162,939 Land & buildings 2021: € 162,939 First fiscal year in the series	€ 148,593 Land & buildings 2022: € 148,593 ▼ 9% vs 2021 (€ 162,939) Unchanged	€ 214,697 Land & buildings 2023: € 214,697 ▲ 44% vs 2022 (€ 148,593) Unchanged	€ 201,112 Land & buildings 2024: € 201,112 ▼ 6% vs 2023 (€ 214,697) Unchanged	▼ 6%
Retained profit	€ 300,684 Retained profit 2021: € 300,684 First fiscal year in the series	€ 336,282 Retained profit 2022: € 336,282 ▲ 12% vs 2021 (€ 300,684) Favourable step	€ 287,401 Retained profit 2023: € 287,401 ▼ 15% vs 2022 (€ 336,282) Unfavourable step	€ 325,466 Retained profit 2024: € 325,466 ▲ 13% vs 2023 (€ 287,401) Favourable step	▲ 13%
Bank debt	€ 89,640 Bank debt 2021: € 89,640 First fiscal year in the series	€ 55,586 Bank debt 2022: € 55,586 ▼ 38% vs 2021 (€ 89,640) Favourable step	€ 69,081 Bank debt 2023: € 69,081 ▲ 24% vs 2022 (€ 55,586) Unfavourable step	€ 92,821 Bank debt 2024: € 92,821 ▲ 34% vs 2023 (€ 69,081) Unfavourable step	▲ 34%
Balance sheet total	€ 451,245 Balance sheet total 2021: € 451,245 First fiscal year in the series	€ 453,675 Balance sheet total 2022: € 453,675 ▲ 1% vs 2021 (€ 451,245) Unchanged	€ 548,719 Balance sheet total 2023: € 548,719 ▲ 21% vs 2022 (€ 453,675) Unchanged	€ 507,675 Balance sheet total 2024: € 507,675 ▼ 7% vs 2023 (€ 548,719) Unchanged	▼ 7%

Key figures of IDEMMED, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to IDEMMED?

What happened at IDEMMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 17, 2025 New annual accounts for financial year 2024: profit of € 38,065. filed late Source: NBB ↗
2020 Pol POPADINEC became a director. NBB
Oct 1, 2016 New establishment in Chapelle-lez-Herlaimont. KBO
Jul 20, 2004 New establishment in Chapelle-lez-Herlaimont. KBO
Jul 20, 2004 Start of the company according to the CBE. KBO

In short

From € 90,279 profit in 2021 to € 38,065 profit in 2024.

Paid € 94,121 in corporate taxes since 2021.

Best year ever: 2021, with € 90,279 profit.

Original PDFs at the National Bank ↗

Management

Pol POPADINEC

IDEMMED

Behind IDEMMED is Pol POPADINEC.

Directors

According to the 2024 annual accounts

Pol POPADINEC

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Chêne 96

7160 Chapelle-lez-Herlaimont

2.266.283.848

Rue du Chêne 32

7160 Chapelle-lez-Herlaimont

Active since 20 July 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0866.466.653
VAT number: BE 0866.466.653
Registered office: Rue du Chêne 96, 7160 Chapelle-lez-Herlaimont
Names & denominations: IDEMMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 July 2004
Peppol: Active · Active since 25 Apr 2026
Contact: [email protected]
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗